Acutaas chemicals Limited has announced the availability of its earnings call recording to investors and stakeholders, following regulatory compliance requirements. The company held its earnings call on January 28, 2026, and has now made the recording accessible through its official website.

Regulatory Compliance and Disclosure

The earnings call recording has been made available in accordance with Regulation 30 and 46(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This disclosure represents a continuation of the company's regulatory obligations, following an earlier intimation about the earnings call that was submitted on January 22, 2026.

Access Information

Investors and stakeholders can access the earnings call recording through the company's official website. The recording has been made available through a dedicated download link, ensuring easy accessibility for all interested parties. The company has provided specific access details to facilitate investor engagement and maintain transparency in its communications.

Corporate Governance

The disclosure was formally communicated to both major stock exchanges where the company's shares are listed. Ekta Kumari Srivastava, Company Secretary & Compliance Officer, signed the regulatory filing, ensuring proper authorization and compliance with corporate governance standards. The communication was digitally signed on January 28, 2026, at 18:30:53 +05'30', demonstrating the company's commitment to timely and accurate regulatory reporting.

Acutaas Chemicals has announced a positive revision to its revenue growth forecast, raising the projection from 25% to approximately 30%. This upward adjustment reflects the company's strengthened business outlook and improved operational performance.

Revised Growth Projections

The company has updated its revenue growth expectations, demonstrating management's increased confidence in business performance. The following table summarizes the forecast revision:

Business Outlook Enhancement

The upward revision of the revenue growth forecast indicates several positive developments for Acutaas Chemicals. The adjustment from 25% to approximately 30% suggests that the company is experiencing stronger market demand and improved operational efficiency than initially anticipated.

This forecast enhancement reflects management's assessment of current business conditions and market opportunities. The increased growth target demonstrates the company's ability to capitalize on favorable market dynamics and operational improvements.

Market Positioning

The revised growth forecast positions Acutaas Chemicals for stronger financial performance in the current period. The 5 percentage point increase in the revenue growth target indicates that the company's business fundamentals are performing above initial expectations.

The enhanced forecast suggests that Acutaas Chemicals is successfully navigating market conditions and leveraging growth opportunities across its business segments.